These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recent and past use of conjugated estrogens in relation to adenocarcinoma of the endometrium. Shapiro S, Kaufman DW, Slone D, Rosenberg L, Miettinen OS, Stolley PD, Rosenshein NB, Watring WG, Leavitt T, Knapp RC. N Engl J Med; 1980 Aug 28; 303(9):485-9. PubMed ID: 6248785 [Abstract] [Full Text] [Related]
3. Increased risk of endometrial carcinoma among users of conjugated estrogens. Ziel HK, Finkle WD. N Engl J Med; 1975 Dec 04; 293(23):1167-70. PubMed ID: 171569 [Abstract] [Full Text] [Related]
13. The risk of breast cancer after estrogen and estrogen-progestin replacement. Bergkvist L, Adami HO, Persson I, Hoover R, Schairer C. N Engl J Med; 1989 Aug 03; 321(5):293-7. PubMed ID: 2546079 [Abstract] [Full Text] [Related]
16. Estrogen regimen of women with endometrial carcinoma. A retrospective case-control study at Radiumhemmet. Obrink A, Bunne G, Collén J, Tjernberg B. Acta Obstet Gynecol Scand; 1981 Aug 03; 60(2):191-7. PubMed ID: 7246086 [Abstract] [Full Text] [Related]